Matthew Kyle Mattson

age ~49

from Homer, AK

Get Report

Also known as:

Matthew K Mattson
Matthew E Mattson
Matthew K Marrson
Mathew K Mattson
Meredith Mattison

Connected to:

Matthew Mattson Phones & Addresses

Homer, AK
Napa, CA
Oakland, CA
1175 Francisco St, San Francisco, CA 94109 • 4153451221
Anchorage, AK
Palo Alto, CA
Kihei, HI
Fairbanks, AK
1515 Latouche St APT 6, Anchorage, AK 99501

Work

Company:

Flashpoints on kpfa radio
Position:

Intern

Education

School / High School:

California State University- Hayward, CA
Sep 2010
Specialities:

Bachelor of Arts in Communication

Resumes

Matthew Mattson Hayward, CA

view source

Work:

Flashpoints on KPFA Radio

Intern Live@The Vertex

Front of House Sound Director The Olive Garden
Hayward, CA
Server

Education:

California State University
Hayward, CA
Sep 2010 to Dec 2012
Bachelor of Arts in Communication Allan Hancock College
Santa Maria, CA
Aug 2008 to Jan 2010
Associate of Arts in Transfer Studies Ernest Righetti High School
Santa Maria, CA
Jun 2008
Diploma

Us Patents

Bridged N-Cyclic Sulfonamido Inhibitors Of Gamma Secretase
view source
US Patent:

7345056, Mar 18, 2008
Filed:

Aug 18, 2006
Appl. No.:

11/465726
Inventors:

Simeon Bowers - Oakland CA, US
Albert W. Garofalo - South San Francisco CA, US
Roy K. Hom - San Francisco CA, US
Andrei W. Konradi - Burlingame CA, US
Matthew N. Mattson - Santa Clara CA, US
Martin L. Neitzel - Pacifica CA, US
Christopher M. Semko - Fremont CA, US
Anh P. Truong - Burlingame CA, US
Jing Wu - Redwood City CA, US
Ying-zi Xu - Palo Alto CA, US
Assignee:

Elan Pharmaceuticals, Inc. - So. San Francisco CA
International Classification:

A01N 43/42
A61K 31/44
C07D 487/00
C07D 491/00
C07D 451/02
US Classification:

514304, 540477, 546124, 546112
Abstract:

The invention provides N-cyclic sulfonamido compounds and salts of Formula I:.

Treatment Of Myopia
view source
US Patent:

7727544, Jun 1, 2010
Filed:

May 9, 2005
Appl. No.:

11/124673
Inventors:

Daniel M. Schwartz - San Francisco CA, US
Chang Jun Yu - Pasadena CA, US
Robert H. Grubbs - Pasadena CA, US
Julia A. Kornfield - Pasadena CA, US
Scott E. Fraser - Lacanada-flintridge CA, US
Matthew S. Mattson - Pasadena CA, US
Assignee:

The Regents of the University of California - Oakland CA
California Institute of Technology - Pasadena CA
International Classification:

A61F 2/00
A61K 31/74
US Classification:

424427, 424 7808
Abstract:

The present invention relates to altering the physical and/or chemical properties of at least part of at least one tissue in the eye. In a specific embodiment, it relates to the treatment and/or prevention of myopia. An activating energy source is utilized to photopolymerize or crosslink molecules in the sclera, thereby increasing the strength of the tissue. The individual is administered a crosslinking reagent or photopolymerizable molecule that becomes associated with the membrane, which is then precisely exposed to an energy source, such as light or ultrasound.

Bridged N-Cyclic Sulfonamido Inhibitors Of Gamma Secretase
view source
US Patent:

7754712, Jul 13, 2010
Filed:

Dec 5, 2007
Appl. No.:

11/951097
Inventors:

Simeon Bowers - Oakland CA, US
Albert W. Garofalo - South San Francisco CA, US
Roy K. Hom - San Francisco CA, US
Andrei W. Konradi - Burlingame CA, US
Matthew N. Mattson - Santa Clara CA, US
Martin L. Neitzel - Pacifica CA, US
Christopher M. Semko - Fremont CA, US
Anh P. Truong - Burlingame CA, US
Jing Wu - Redwood City CA, US
Ying-zi Xu - Palo Alto CA, US
Assignee:

Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:

A61K 31/5365
A61K 31/437
A61K 31/4985
A61P 25/28
C07D 497/04
C07D 497/14
C07D 471/14
US Classification:

5142302, 5142305, 514250, 514293, 544101, 544105, 544346, 546 82
Abstract:

The invention provides N-cyclic sulfonamido compounds and salts of Formula I:wherein A is as described in the specification and Rand Rcombine to form a [3. 3. 1] or a [3. 2. 1] ring system, where the nitrogen is attached to the two bridgehead carbons, and the [3. 3. 1] or [3. 2. 1] ring systems are optionally fused with an heteroaryl or heterocycloalkyl ring. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula I, methods of treating cognitive disorders, such as Alzheimer's disease, and the intermediates useful in preparing the compounds of Formula I.

Pyrazolopyrrolidines As Inhibitors Of Gamma Secretase
view source
US Patent:

7977368, Jul 12, 2011
Filed:

May 21, 2008
Appl. No.:

12/124358
Inventors:

Darren Dressen - Fremont CA, US
Simeon Bowers - Oakland CA, US
Albert W. Garofalo - South San Francisco CA, US
Roy K. Hom - San Francisco CA, US
Matthew N. Mattson - Santa Clara CA, US
Assignee:

Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:

A61K 31/40
A61K 31/4162
C07D 231/54
US Classification:

514406, 514360, 514408, 514422, 548122, 548400, 548416, 548418, 548518
Abstract:

The invention provides compounds of Formula I.

Bridged N-Cyclic Sulfonamido Inhibitors Of Gamma Secretase
view source
US Patent:

20110003802, Jan 6, 2011
Filed:

Jul 6, 2010
Appl. No.:

12/830914
Inventors:

Simeon Bowers - Oakland CA, US
Albert W. Garofalo - South San Francisco CA, US
Roy K. Hom - San Francisco CA, US
Andrei W. Konradi - Burlingame CA, US
Matthew N. Mattson - Santa Clara CA, US
Martin L. Neitzel - Pacifica CA, US
Christopher M. Semko - Fremont CA, US
Anh P. Truong - Burlingame CA, US
Jing Wu - Redwood City CA, US
Ying-zi Xu - Palo Alto CA, US
Assignee:

Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:

A61K 31/5383
C07D 498/06
C07D 498/16
C07D 453/02
C07D 471/16
C07D 487/06
C07D 487/16
A61K 31/439
A61K 31/4995
A61P 25/28
US Classification:

5142302, 544105, 544101, 546137, 546 82, 544349, 544346, 5142305, 514305, 514293, 514249, 514250
Abstract:

The invention provides N-cyclic sulfonamido compounds and salts of Formula I:wherein A is as described in the specification and Rand Rcombine to form a [3.3.1] or a [3.2.1] ring system, where the nitrogen is attached to the two bridgehead carbons, and the [3.3.1] or [3.2.1] ring systems are optionally fused with an heteroaryl or heterocycloalkyl ring. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula I, methods of treating cognitive disorders, such as Alzheimer's disease, and the intermediates useful in preparing the compounds of Formula I.

Bridged N-Bicyclic Sulfonamido Inhibitors Of Gamma Secretase
view source
US Patent:

20110178119, Jul 21, 2011
Filed:

Aug 18, 2006
Appl. No.:

12/090616
Inventors:

Andrei W. Konradi - Burlingame CA, US
Matthew N. Mattson - Santa Clara CA, US
Christopher M. Semko - Fremont CA, US
Xiaocong Michael Ye - Palo Alto CA, US
Assignee:

ELAN PHARMACEUTICALS, INC. - South San Francisco CA
International Classification:

A61K 31/439
C07D 221/02
A61P 25/28
US Classification:

514299, 546183, 546112
Abstract:

The invention provides N-bicyclic sulfonamido compounds of Formula (I) wherein A is as described in the specification and Rand Rcombine to form a [3.3.1] or a [3.2.1] ring system. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of treating cognitive disorders, such as Alzheimer's disease.